Skip to main content
SpringerLink
Log in

Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707–717

    Article  PubMed  CAS  Google Scholar 

  2. Bitsch A, Bruck W (2002) Differentiation of multiple sclerosis subtypes: implications for treatment. CNS Drugs 16:405–418

    Article  PubMed  CAS  Google Scholar 

  3. Keegan M, Konig F, McClelland R, et al. (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579–582

    Article  PubMed  Google Scholar 

  4. Polman CH, Reingold SC, Edan G, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol 58:840–846

    Article  PubMed  Google Scholar 

  5. Selkirk SM, Shi J (2005) Relapsing-remitting tumefactive multiple sclerosis. Mult Scler 11:731–734

    Article  PubMed  Google Scholar 

  6. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270–1272

    PubMed  CAS  Google Scholar 

  7. Stuve O, Cepok S, Elias B, et al. (2005) Clinical stabilization and effective Blymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis. Arch Neurol 62:1620–1623

    Article  PubMed  Google Scholar 

  8. Chan A, Lee DH, Linker R, et al. (2007) Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease. J Neurol 254:1604–1606

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentrum für Medizinische Rehabilitation – Neurologie, Grenzweg 3, 33617, Bielefeld, Germany

    M. R. Haupts

  2. Dept. of Neurology, Ruhr University Bochum, Knappschaftskrankenhaus, In der Schornau 23–25, 44892, Bochum, Germany

    M. R. Haupts, G. Ahle & U. Schlegel

  3. Dept. of Neurology, Ruhr University Bochum, St. Josef-Hospital, 44791, Bochum, Germany

    S. K. Schimrigk, N. Brune, A. Chan, K. Hellwig & R. Gold

  4. Dept. of Neuropathology, University of Göttingen, 37099, Göttingen, Germany

    F. B. König & W. Brück

Authors
  1. M. R. Haupts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. K. Schimrigk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Brune
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Ahle
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Hellwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. B. König
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. U. Schlegel
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Brück
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Drs. Haupts and Schimrigk contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haupts, M.R., Schimrigk, S.K., Brune, N. et al. Fulminant tumefactive multiple sclerosis: Therapeutic implications of histopathology. J Neurol 255, 1272–1273 (2008). https://doi.org/10.1007/s00415-008-0883-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0883-x

Keywords

Search

Navigation